5D(L0N|!!~ZF8<V1/%|QV5>X9[3(B&
SYSTEM PROCESSING...
5D(L0N|!!~ZF8<V1/%|QV5>X9[3(B&
SYSTEM PROCESSING...
Posted: 2025-06-02 14:04:54 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-06-02 14:05:47 UTC
Verified By
Rollup News
The text discusses MucoRice, an oral rice-based vaccine being developed by Asahi Kogyosha in collaboration with Chiba University. It highlights the potential for mass production and distribution without refrigeration, making it suitable for developing countries and disaster situations. MucoRice aims to prevent diseases like cholera and influenza.
Development of MucoRice, an oral rice-based vaccine.
Potential for mass production and distribution without refrigeration.
Suitability for developing countries and disaster situations.
Prevention of diseases like cholera and influenza.
Gaining public trust in genetically modified crops.
Ensuring consistent vaccine efficacy across different rice batches.
Scaling up production to meet global demand.